不穏な足症候群の患者に対するPaeoniae Radixを含むハーブ医薬品の効果: 経歴レビュー研究
Young Seon Lee1, Han-Gyul Lee2, Seungwon Kwon3
1Department of Clinical Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, South Korea.
World journal of clinical cases
|August 29, 2025
まとめ
Paeoniae Radix (HCP) を含んだ薬草は,不安足症候群 (RLS) の症状と患者の報告した不快感を有意に改善しました. この研究は,HCPがRLS患者の安全で効果的な代替治療法であることを示唆しています.
科学分野:
- 神経学
- 統合医療
- 薬草 の 薬
背景:
- 落ち着かない足症候群 (RLS) は,制御不能な足の動きを促す神経疾患です.
- 現在の治療法では 長期的な緩和が限られており 副作用も発生する可能性があります
- パオニア・ラジックス (HCP) を含んだ薬草は,韓国では伝統的にRLSの治療に使われています.
研究 の 目的:
- RLS の治療における HCP の臨床的効果と安全性を評価する.
- RLSの症状の重度と患者の報告したアウトカムに対する HCPの影響を評価する.
主な方法:
- HCPで治療された15人のRLS患者の遡及的チャートレビュー
- 人口統計,病気,治療の特徴の分析
- 主観的なRLSの苦情の評価,韓国版の国際不安脚スケール (K-IRLS) のスコア,および有害事象.
主要な成果:
- 93. 3% の患者は,HPの治療後に症状の不快感が軽減された.
- 平均K-IRLSスコアは23. 00から13. 93に大幅に低下した (P=0. 005).
- GyejibokryeonghwanとJakyakgamchotangの配方ではK- IRLSスコアが著しく低下し,有害事象は報告されなかった.
結論:
- RLSの症状と患者の報告したアウトカムを効果的に改善しました.
- HCPはRLSの安全で効果的な代替治療の可能性を示しています.
- これらの発見を検証するために,さらなるランダム化対照試験が推奨されます.
さらに関連する動画
関連する概念動画
01:27Restless Leg Syndrome and Night Terrors
249
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
249
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
238
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
238
01:27Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
251
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
251
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
34
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
34
01:24Parkinson's Disease: Treatment
376
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
376